home / stock / mnpr / mnpr news

MNPR News and Press, Monopar Therapeutics Inc. From 09/14/25

Stock Information
Company Name: Monopar Therapeutics Inc.
Stock Symbol: MNPR
Market: NASDAQ
Website: monopartx.com
Menu
MNPR MNPR Quote MNPR Short MNPR News MNPR Articles MNPR Message Board
Get MNPR Alerts

News, Short Squeeze, Breakout and More Instantly...
MNPR - Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting

WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that new data on...
MNPR - Monopar Therapeutics: A Speculative Buy On 2 Fronts With Catalysts Imminent

2025-09-04 10:29:48 ET Monopar Overview - IPO, Management, Lead Drug Candidate This is my first time covering Monopar Therapeutics Inc. ( MNPR ) for Seeking Alpha - first let's consider a business overview provided by the company in its Q2 2025 quarterly report / 10Q filin...

MNPR - Monopar a new outperform at Oppenheimer on Wilson disease candidate

2025-09-03 11:29:24 ET More on Monopar Therapeutics Seeking Alpha’s Quant Rating on Monopar Therapeutics Historical earnings data for Monopar Therapeutics Financial information for Monopar Therapeutics Read the full article on Seeking Alpha For...

MNPR - Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting

WILMETTE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced that ...
MNPR - Monopar Therapeutics files $300M mixed securities shelf

2025-08-29 16:52:28 ET More on Monopar Therapeutics Seeking Alpha’s Quant Rating on Monopar Therapeutics Historical earnings data for Monopar Therapeutics Financial information for Monopar Therapeutics Read the full article on Seeking Alpha For...

MNPR - Monopar Therapeutics reports Q2 results

2025-08-12 09:31:56 ET More on Monopar Therapeutics Seeking Alpha’s Quant Rating on Monopar Therapeutics Historical earnings data for Monopar Therapeutics Financial information for Monopar Therapeutics Read the full article on Seeking Alpha For...

MNPR - Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments

WILMETTE, Ill., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced...
MNPR - Expected US Company Earnings on Friday, August 8th, 2025

Hudson Global Inc. (HSON) is expected to report $0.17 for Q2 2025 Meritage Hospitality Group Inc. (MHGU) is expected to report $0.54 for Q2 2025 Genprex Inc. (GNPX) is expected to report for Q2 2025 Hour Loop Inc. (HOUR) is expected to report for Q2 2025 New Fortress Energy Inc. (...

MNPR - Expected earnings - Monopar Therapeutics Inc.

Monopar Therapeutics Inc. (MNPR) is expected to report $-0.47 for Q2 2025

MNPR - MNPR - Historical Price Movements Surrounding Earnings

2025-08-07 18:45:19 ET Monopar Therapeutics Inc. (MNPR) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.43%. The average open to low on the day of earnings was -10.78%. The average ope...
Previous 10 Next 10